Church & Dwight Co., Inc. (NYSE:CHD) Shares Sold by Kentucky Retirement Systems

Kentucky Retirement Systems trimmed its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 1.5% in the second quarter, Holdings Channel reports. The institutional investor owned 18,426 shares of the company’s stock after selling 285 shares during the period. Kentucky Retirement Systems’ holdings in Church & Dwight were worth $1,910,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Nomura Holdings Inc. lifted its stake in Church & Dwight by 442.1% during the fourth quarter. Nomura Holdings Inc. now owns 14,148 shares of the company’s stock worth $1,338,000 after purchasing an additional 11,538 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its position in shares of Church & Dwight by 13.1% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 342,699 shares of the company’s stock valued at $35,755,000 after buying an additional 39,695 shares during the last quarter. Russell Investments Group Ltd. grew its position in shares of Church & Dwight by 12.8% in the 1st quarter. Russell Investments Group Ltd. now owns 208,997 shares of the company’s stock valued at $21,798,000 after buying an additional 23,754 shares during the last quarter. Cim LLC acquired a new stake in Church & Dwight during the 4th quarter worth $3,188,000. Finally, UBS Group AG lifted its position in Church & Dwight by 16.1% in the fourth quarter. UBS Group AG now owns 619,433 shares of the company’s stock valued at $58,574,000 after acquiring an additional 86,045 shares during the last quarter. 86.60% of the stock is owned by institutional investors and hedge funds.

Church & Dwight Price Performance

Church & Dwight stock opened at $103.45 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.98 and a current ratio of 1.53. Church & Dwight Co., Inc. has a one year low of $82.25 and a one year high of $110.31. The company has a market cap of $25.33 billion, a P/E ratio of 32.84, a price-to-earnings-growth ratio of 3.55 and a beta of 0.54. The business has a fifty day moving average of $102.00 and a two-hundred day moving average of $104.21.

Church & Dwight (NYSE:CHD) last released its quarterly earnings data on Friday, August 2nd. The company reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.09. Church & Dwight had a net margin of 13.38% and a return on equity of 19.86%. The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same quarter in the previous year, the firm earned $0.92 earnings per share. The firm’s revenue was up 3.9% on a year-over-year basis. As a group, analysts predict that Church & Dwight Co., Inc. will post 3.43 earnings per share for the current fiscal year.

Church & Dwight Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 3rd. Investors of record on Thursday, August 15th were issued a dividend of $0.2838 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.14 annualized dividend and a yield of 1.10%. Church & Dwight’s dividend payout ratio is presently 35.87%.

Insiders Place Their Bets

In other news, EVP Barry A. Bruno sold 59,328 shares of the firm’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $99.37, for a total value of $5,895,423.36. Following the completion of the transaction, the executive vice president now owns 4,319 shares in the company, valued at $429,179.03. The sale was disclosed in a document filed with the SEC, which is available at this link. 2.00% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on CHD shares. Truist Financial dropped their price objective on Church & Dwight from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, August 5th. Stifel Nicolaus reduced their price objective on Church & Dwight from $107.00 to $105.00 and set a “hold” rating for the company in a research note on Monday, August 5th. BNP Paribas assumed coverage on shares of Church & Dwight in a report on Monday, June 24th. They issued a “neutral” rating and a $114.00 target price on the stock. Wells Fargo & Company reduced their price target on shares of Church & Dwight from $116.00 to $108.00 and set an “overweight” rating for the company in a research report on Monday, August 5th. Finally, Evercore ISI lowered their price objective on shares of Church & Dwight from $110.00 to $101.00 and set an “in-line” rating on the stock in a research report on Monday, August 5th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $106.58.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.